NCT00707876View on ClinicalTrials.gov

Magnetic Resonance Angiography for Peripheral Arterial Disease (PAD)

PHASE2UnknownINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

July 31, 2010

Study Completion Date

August 31, 2019

Conditions
Peripheral Arterial Disease (PAD)
Interventions
DRUG

ferumoxytol

Dose 1 versus non-contrast MRA

DRUG

ferumoxytol

Dose 2 versus non-contrast MRA

DRUG

ferumoxytol

Dose 3 versus non-contrast MRA

Trial Locations (1)

02421

Lexington

Sponsors
All Listed Sponsors
lead

AMAG Pharmaceuticals, Inc.

INDUSTRY